To provide a composition for diagnosing and/or treating cancerous pathologies in the field of urology.
The invention relates to a 5-aminolevulinic acid ester (E-ALA) solution for producing a pharmaceutical preparation useful for diagnosing and/or treating tissue pathologies and/or cell pathologies by local radiation exposure using radiation emitted by a light source energy followed, in the case diagnosis, by detection of fluorescent protoporphyrin IX (PpIX). The E-ALA concentration (c) in the solution is less than 1% and ranges between 0.01 to 0.5%. The low E-ALA concentration in the solution increases the synthesis of PpIX and homogenizes its distribution in the cell layers while highly reducing the secondary toxicity for the treated cells.
COPYRIGHT: (C)2010,JPO&INPIT
LANGE NORBERT
ZELLWEGER MATTHIEU
WAGNIERES GEORGE
VAN DEN BERGH HUBERT
JICHLINSKI PATRICE
KUCERA PAVEL
LANGE NORBERT
JICHLINSKI PATRICE
KUCERA PAVEL
ECOLE POLYTECH
WO1996028412A1 | 1996-09-19 |